Moran Landhing M, Fitting Sylvia, Booze Rosemarie M, Webb Katy M, Mactutus Charles F
University of South Carolina, Behavioral Neuroscience Program, Department of Psychology, Columbia, SC 29208, USA.
University of South Carolina, Behavioral Neuroscience Program, Department of Psychology, Columbia, SC 29208, USA.
Int J Dev Neurosci. 2014 Nov;38:195-203. doi: 10.1016/j.ijdevneu.2014.09.004. Epub 2014 Oct 5.
Pediatric AIDS caused by human immunodeficiency virus type 1 (HIV-1) remains one of the leading worldwide causes of childhood morbidity and mortality. HIV-1 proteins, such as Tat and gp120, are believed to play a crucial role in the neurotoxicity of pediatric HIV-1 infection. Detrimental effects on development, behavior, and neuroanatomy follow neonatal exposure to the HIV-1 viral toxins Tat1-72 and gp120. The present study investigated the neurobehavioral effects induced by the HIV-1 neurotoxic protein Tat1-86, which encodes the first and second exons of the Tat protein. In addition, the potential effects of HIV-1 toxic proteins Tat1-86 and gp120 on inflammatory pathways were examined in neonatal brains. Vehicle, 25 μg Tat1-86 or 100 ng gp120 was injected into the hippocampus of male Sprague-Dawley pups on postnatal day 1 (PD1). Tat1-86 induced developmental neurotoxic effects, as witnessed by delays in eye opening, delays in early reflex development and alterations in prepulse inhibition (PPI) and between-session habituation of locomotor activity. Overall, the neurotoxic profile of Tat1-86 appeared more profound in the developing nervous system in vivo relative to that seen with the first exon encoded Tat1-72 (Fitting et al., 2008b), as noted on measures of eye opening, righting reflex, and PPI. Neither the direct PD1 CNS injection of the viral HIV-1 protein variant Tat1-86, nor the HIV-1 envelope protein gp120, at doses sufficient to induce neurotoxicity, necessarily induced significant expression of the inflammatory cytokine IL-1β or inflammatory factors NF-κβ and I-κβ. The findings agree well with clinical observations that indicate delays in developmental milestones of pediatric HIV-1 patients, and suggest that activation of inflammatory pathways is not an obligatory response to viral protein-induced neurotoxicity that is detectable with behavioral assessments. Moreover, the amino acids encoded by the second tat exon may have unique actions on the developing hippocampus.
由1型人类免疫缺陷病毒(HIV-1)引起的小儿艾滋病仍然是全球儿童发病和死亡的主要原因之一。据信,HIV-1蛋白,如Tat和gp120,在小儿HIV-1感染的神经毒性中起关键作用。新生儿接触HIV-1病毒毒素Tat1-72和gp120后,会对发育、行为和神经解剖结构产生有害影响。本研究调查了HIV-1神经毒性蛋白Tat1-86(其编码Tat蛋白的第一和第二个外显子)诱导的神经行为影响。此外,还研究了HIV-1毒性蛋白Tat1-86和gp120对新生鼠脑内炎症途径的潜在影响。在出生后第1天(PD1),将溶媒、25μg Tat1-86或100ng gp120注射到雄性斯普拉格-道利幼鼠的海马体中。Tat1-86诱导了发育性神经毒性作用,表现为睁眼延迟、早期反射发育延迟以及前脉冲抑制(PPI)和运动活动的会话间习惯化改变。总体而言,与编码第一个外显子的Tat1-72相比,Tat1-86在体内发育中的神经系统中的神经毒性特征似乎更为明显(Fitting等人,2008b),这在睁眼、翻正反射和PPI测量中得到了体现。无论是直接在PD1时将HIV-1病毒蛋白变体Tat1-86注射到中枢神经系统,还是注射足以诱导神经毒性剂量的HIV-1包膜蛋白gp120,都不一定会诱导炎性细胞因子IL-1β或炎性因子NF-κβ和I-κβ的显著表达。这些发现与临床观察结果高度一致,临床观察表明小儿HIV-1患者的发育里程碑存在延迟,并表明炎症途径的激活并非病毒蛋白诱导的神经毒性的必然反应,而这种反应可通过行为评估检测到。此外,tat第二个外显子编码的氨基酸可能对发育中的海马体具有独特作用。